Skip to content
ShapeTX
  • About
  • Careers
  • News & Blog
  • Contact

In the news

ShapeTX in the News

Company News
Media Mentions
Blog
News and Publications

Company News


See All

September 7, 2023

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

June 20, 2023

ShapeTX Announces the Appointment of Adrian W. Briggs, Ph.D. As Chief Technology Officer

May 4, 2023

ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond

Media Mentions


See All
23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022)

23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022)

Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022)

Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022)

Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022)

Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022)

Blog


See All
How AI will revolutionize drug discovery: ShapeTX CEO Francois Vigneault on Tech Nation

How AI will revolutionize drug discovery: ShapeTX CEO Francois Vigneault on Tech Nation

Spotlight Video: Solving puzzles as a team

Spotlight Video: Solving puzzles as a team

Generative AI is creating the next generation of therapies: programmable medicine

Generative AI is creating the next generation of therapies: programmable medicine

ShapeTX at ASGCT 2023: Programmable Medicine Takes Center Stage

ShapeTX at ASGCT 2023: Programmable Medicine Takes Center Stage

Spotlight Video: Charting New Courses

Spotlight Video: Charting New Courses

Dispatches from The Atlantic Progress Summit: How mRNA Technology Could Save the World

Dispatches from The Atlantic Progress Summit: How mRNA Technology Could Save the World

News and Publications


See All

The future of programmable RNA medicine

About Careers News & Blog Contact
Seattle

700 Dexter Ave N
Seattle, WA 98109

Boston

17 Drydock Ave
Boston, MA 02210

© 2023 Shape TX

Privacy Policy
© 2023 ShapeTX • Built with GeneratePress

The future of programmable RNA medicine

  • About
  • Careers
  • News & Blog
  • Contact

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases